Published

Metsera raises $215m in Series B round for weight loss candidates - Pharmaceutical Technology

Summary by Pharmaceutical-technology.com
Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)